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Abstract The p21-GTPase activated kinase, PAK1, and the
mixed lineage kinase, MLK2, have been implicated in the acti-
vation of jun N-terminal kinase (JNK). However, the role of
PAK1 in JNK activation is still not understood. Here we show
that over-expression of the SH3-SH2 adapter Nck ‘squelches’
JNK activation but this squelching is relieved by over-expression
of PAK1. In turn, PAK1 squelches activation of JNK by MLK2
and these kinases interact via their catalytic domains. The data
suggest that PAK1 recruits MLK2 to an activated receptor via
the adapter Nck, but cannot itself induce activation of the JNK
cascade.
0 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The response of cells to extracellular signals is mediated in
large part by the three mitogen activated protein kinase
(MAPK) pathways, each terminating in the activation of ei-
ther the extracellular signal regulated kinases ERK1 and 2 or
the stress activated protein kinases SAPK1/JNK (jun N-ter-
minal kinase) and SAPK2/p38/Hog [1,2]. The activated
MAPKs regulate gene expression, providing appropriate cel-
lular responses to extracellular signals. The JNK pathway has
been shown to be important for Wnt signaling during early
development and to mediate responses to cytokines and arti-
¢cially induced stresses caused by UV irradiation or poisons
such as arsenite and anisomycin. While many of the compo-
nents of the JNK pathway have been identi¢ed, the manner in
which the signal is transduced from the membrane receptor
still remains elusive. The Rac/Cdc42 family of p21-like
GTPases have been shown to induce JNK activation [3,4],
suggesting that they could do so in a manner resembling the
Ras activation of the ERK cascade [5]. However, the link
between Rac/Cdc42 and the activation of JNK also remains
obscure.
Each of the MAPK pathways consists of a four-level kinase
cascade, the MAPK, a MAPK kinase (MAP2K), a MAPK
kinase kinase (MAP3K) and often a MAPK kinase kinase
kinase (MAP4K). Cascade modules are probably assembled
onto a protein sca¡old and may be recruited as such to trans-
duce signals from the plasma membrane to the appropriate
MAPK [2]. In the case of JNK, the sca¡old protein JIP has
been shown to assemble the MAP3K mixed lineage kinase 3
(MLK3), the MAP2K, MKK7, and JNK into a module po-
tentially capable of transducing signals from the MAP4K,
HPK1 [6,7]. HPK1, a member of the germinal centre kinase
(GCK) subfamily of Ste20/p21-GTPase activated kinase
(PAK) related kinases, interacts with growth factor receptors
such as EGFR via the Src homology domain 2^3 (SH2^SH3)
adapter proteins Grb2 and Nck and can directly phosphory-
late MLK3 [8,9]. HPK1 is also necessary for TGFL dependent
activation of JNK [10]. However, the GCKs lack a GTPase
binding domain (GBD) or CRIB motif and hence cannot
transduce signals from Rac/Cdc42. On the other hand
MLK3 does contain a Cdc42 speci¢c GBD [11] and this
GTPase induces MLK3 activation in vivo [12].
The Ste20 related PAKs were ¢rst identi¢ed as Rac/Cdc42
activated kinases [13]. PAK1 was later shown to interact con-
stitutively with the adapter Nck and recruitment of this com-
plex to EGF and PDGF receptors led to its activation [14,15].
Over-expression of the mammalian PAKs can cause JNK ac-
tivation; however, the data supporting an integral role for
PAK in the JNK cascade are equivocal. Brown et al. [16]
demonstrated that while over-expression of wild-type (wt)
hPAK1 did not activate JNK1 in COS7 cells, a 95-fold con-
stitutively over-activated hPAK1 GBD mutant (L107F) did
induce an eight-fold activation of JNK. Similarly, Bagrodia
et al. [17] demonstrated that in COS1 cells a GBD mutant
mPAK3 (F91S,G93A,P95A) activated hJNK1. Over-expres-
sion of wt rPAK1 and 2 in human kidney ¢broblasts (293
cells) activated JNK1, but in contrast suppressed the activa-
tion of JNK by constitutively active Rac and Cdc42, [18,19],
and PAK65 was not essential for JNK activation in NIH3T3
cells [20]. MEKK1, a possible MAP3K of the JNK cascade,
has also been shown to be activated during coinfection of
insect cells with virus vectors expressing MEKK1 and
PAK3. However, this e¡ect was clearly indirect as MEKK1
was not a substrate for phosphorylation by PAK3 [21].
Here we show that while Xenopus MLK2 activates JNK in
an extracellular signal dependent manner, Xenopus PAK1 is
unable to activate JNK. However, PAK1 relieved Nck medi-
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ated suppression of JNK activation but suppressed MLK2
activation of JNK. The data suggest that PAK1 functions
as a sca¡old linking the JNK cascade to activated RTKs
via Nck.
2. Materials and methods
2.1. Expression vectors
The coding region for amino acids 2^527 of Xenopus PAK1 [22]
(GenBank accession number AF169794) was HA tagged
(MYDVPDYASLPGNSNNAL-) and subcloned HindIIIGenBankX-
baI into pCDNA3 (Clontech). The coding region for amino acids
2^1005 of Xenopus MLK2; [23] (GenBank accession number
AF510499) was also HA tagged (MYDVPDYASLPGNDGLP-) and
cloned into pCDNA3 HindIIIGenBankXbaI. Expression vectors for
human NckK and JNK2, (SAPK1L) were kindly provided by J.
Schlessinger and by J. Landry.
2.2. Cell culture and transfection
COS7 cells [24] were cultured in Dulbecco’s modi¢ed Eagle’s me-
dium (DMEM) supplemented with 10% fetal calf serum. The day
before transfection, 3U105 cells were plated on 100 mm tissue culture
dishes. Two hours before the transfection, medium was changed for
fresh medium. A standard CaPO4/chloroquine procedure was used for
transfection with a total of 10 Wg of expression vector. In cases where
combinations of vectors were cotransfected, DNA amounts were
equalized by the addition of the empty pCDNA3 vector. Twenty-
four hours after transfection, cells were lysed in MGE lysis bu¡er
(20 mM MOPS pH 7.0, 10% glycerol, 0.5 mM EDTA, 5 mM
EGTA, 1 mM NaVO4, 5 mM sodium pyrophosphate, 50 mM NaF,
80 mM L-glycerophosphate, 1% Triton X-100, 0.1 mM benzamidine,
0.1 mM dithiothreitol (DTT) and 0.1 mM phenylmethylsulfonyl £uo-
ride (PMSF)) and centrifuged at 17 000 rpm for 10 min. Cleared
lysates were normalized for equal protein concentration of HA-JNK
and, where appropriate, NckK, PAK1 and MLK2 by Western blot-
ting. For UV irradiation and EGF treatment, cells were transferred to
DMEM without serum and immediately treated either with 100 J m32
of UV irradiation using a UVP UVGL-25 (Ultra-Violet Products) or
with 50 ng ml31 human EGF (Life Technologies) in DMEM and
harvested after a subsequent incubation of 5 min or of 1 h, as indi-
cated.
2.3. JNK kinase assays
Cell cleared lysates were incubated with 2 Wg of glutathione^Se-
pharose immobilized GST-c-jun for 20 min on ice and then were
washed ¢ve times with MIKI (20 mM Tris^HCl pH 7.5, 150 mM
NaCl, 0.1 mM EDTA, 1 mM EGTA 1 mM MgCl2, 1 mM NaVO4,
1% Triton X-100 and 1 mM PMSF). Kinase assays were performed in
MPM bu¡er (150 WM ATP, 15 mM MOPS pH 7, 5% glycerol, 60 mM
p-nitrophenylphosphate, 15 mM MgCl2, 1 mM DTT and 0.1 mM
PMSF) in the presence of 3 WCi of [Q-32P]ATP and incubated for
30 min at 30‡C. The reaction was stopped by adding 6Usodium
dodecyl sulfate (SDS) gel loading bu¡er. Phosphoproteins were sepa-
rated by Tris^glycine^SDS^polyacrylamide gel electrophoresis
(PAGE) and transferred to nitrocellulose membranes. 32P incorpora-
tion into GST-c-jun was visualized and measured by phosphorimaging
(Molecular Dynamics).
2.4. PAK kinase assays
Cell cleared lysates were incubated with 5 Wl anti-HA-1 ascites
(12CA5) for 60 min on ice. Ten Wl of a 50% protein A^Sepharose
slurry (Pharmacia) in MIKI was then added and the incubation con-
tinued for another 30 min. The slurry was then washed three times in
500 Wl MIKI and resuspended in one volume (20 Wl) of D2X (50 mM
HEPES pH 7.4, 50 mM L-glycerolphosphate, 50 mM MgCl2, 0.2 mM
NaVO4, 4 mM DTT, 75 WM [Q-32P]ATP (5000 dpm/pmol)) containing
50 ng of myelin basic protein (MBP) (Gibco BRL) and incubated for
30 min at 30‡C. Phosphoproteins were separated on Tris^glycine^
SDS^PAGE and transferred to nitrocellulose membranes. 32P incor-
poration into MBP was visualized and measured by phosphorimaging
(Molecular Dynamics).
2.5. MLK-PAK binding assay
MLK2 truncation mutants -Sph, -A£, -Bam and -Eco were ex-
pressed by synthetic mRNA (Ambion) injection into Xenopus laevis
embryos. Embryos were produced by in vitro fertilization [25]. Two
cell embryos in 0.2UMMR (20 mM NaCl, 0.5 mM KCl, 0.2 mM
MgSO4, 0.5 mM CaCl2, 1 mM HEPES and 0.02 mM EDTA), 5%
Ficoll 400, were injected with 2 ng of MLK2 mRNAs and allowed to
develop for 18 h. Gastrula embryos were lysed in MGE lysis bu¡er
and were centrifuged at 30 000 rpm for 30 min. The clear protein
phase was recovered and analyzed for expression by Western blotting
using the monoclonal antibody 12CA5. Twenty Wl glutathione^Se-
pharose (Amersham Biotech) immobilized full length GST-Xenopus-
PAK1 fusion protein was incubated with the total protein extract
from X. laevis embryos expressing Xenopus MLK2-Sph, -A£, -Bam
and -Eco. After incubation for 20 min on ice, the Sepharose beads
were washed ¢ve times with 0.1 M TM (50 mM Tris^HCl pH 7.9,
100 mM NaCl, 1.5 mM MgCl2, 1 mM EDTA and 20% glycerol).
Sepharose beads were resuspended in SDS^PAGE loading bu¡er
and bound proteins fractionated on Tris^glycine^SDS gels, trans-
ferred on nitrocellulose membranes and probed with the monoclonal
antibody 12CA5 and developed using a HRP coupled second anti-
body (Amersham Biotech) in conjunction with the ‘Renaissance’ ECL
reagent kit (Roche). Alternatively, MLK2-SK and -KZG mutants
were expressed by in vitro translation (Promega) and 10 Wl of the
extract incubated with 1 Wg of immobilized GST-CDPAK1 or GST
alone for 2 h at 4‡C in 50 Wl of phosphate bu¡ered saline (PBS), 1%
Triton X-100. The beads were washed four times with 0.5 ml PBS, 1%
Triton X-100, resuspended in SDS^PAGE loading bu¡er and bound
proteins fractionated on Tris^glycine^SDS gels. Gels were ¢xed and
dried and analyzed by phosphoimaging (STORM 860, Molecular Dy-
namics).
3. Results
3.1. JNK is not activated by PAK1 expression
Consistent with previous studies on mammalian PAKs
[19,20,26], expression of wt and both activated and kinase
dead mutants of Xenopus PAK1, Fig. 1A,B, in COS7 cells
did not signi¢cantly a¡ect the basal levels of JNK activity,
Fig. 1C. Wt PAK1 also did not enhance activation of JNK by
UV irradiation (or sodium arsenite, data not shown), while
activated PAK1s L98F and T405E actually suppressed UV
activation of JNK (up to 30%), and the kinase dead K281A
showed a slight enhancement e¡ect.
3.2. Rapid Nck dependent activation of xPAK1 by EGF but not
by UV stress
Maximal JNK activity typically occurs 30 to 60 min after
UV (or arsenite) treatments, suggesting that JNK activation is
not a direct event. However, both UV stress and EGF treat-
ment induce a rapid and direct, albeit weaker, activation of
JNK and PAK1 recruitment to the activated EGF receptor
via Nck leads to its rapid activation, [14,15,27]. We, therefore,
investigated whether the rapid phase of JNK activation coin-
cided with PAK1 activation. Wt and mutant PAK1s were
transfected with or without Nck and cells then treated with
EGF, UV, or a combination of both and harvested just 5 min
later, Fig. 2A. As expected, EGF induced a rapid, ¢ve-fold
increase in PAK1 activity which was dependent on Nck over-
expression. In contrast, UV did not detectably activate PAK1
and EGF and UV treatments did not cooperate in PAK1
activation.
3.3. PAK1 can relieve Nck suppression of the JNK pathway
Fig. 2B shows the relative levels of JNK activation 5 min
after a mock treatment, EGF treatment or simultaneous UV
and EGF treatments. In the absence of both PAK1 and Nck,
EGF induced JNK activation and the combined EGF and
UV treatments were found to cooperate in a ‘super-activation’
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of JNK. When PAK1 was transfected a small enhancement in
JNK activity after EGF and EGF/UV treatments was ob-
served (6 20%), despite PAK1 not being detectably activated
under these conditions, Fig. 2A. Quite unexpectedly, we found
that the adapter Nck strongly suppressed JNK activation, Fig.
2B. Nck expression reduced EGF and EGF/UV activation of
JNK respectively by 60% and 80%. Nck over-expression was
also shown to suppress signaling in other systems [28,29]. The
e¡ect is believed to be due to non-stochiometric saturation of
upstream or downstream signaling components, a phenome-
non which can be likened to ‘squelching’ (non-stochiometric
expression causing disruption of a multi-protein complex) in
gene regulation [30].
More surprisingly, PAK1 relieved Nck squelching of JNK
activation, Fig. 2B, and re-established the response of JNK to
both EGF and EGF plus UV. Though constitutively activated
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Fig. 1. A: Schematic structure of xPAK1, Nck and xMLK2. xPAK1 schematic shows the positions of known or potential SH3 domain binding
sites (SH3 BS) (white boxes) and the p21ras-like GBD (black box). The position of point mutations are indicated (mutants). xPAK1 L98F and
T405E are constitutively active mutants, K281A and T405A are kinase inactive mutants. Nck contains three SH3 domains and a SH2 domain.
The mixed lineage kinase, xMLK2, contains an N-terminal SH3 domain, a serine/threonine kinase domain, two LZ motifs, a basic region and
a GBD. B: Intrinsic activity of the various PAK1 mutants used in this study. C: Activity of xPAK1 does not correlate with JNK activation in
COS7 cells. JNK activity was measured in extracts prepared from cells transfected with xPAK1 mutants and irradiated (UV), or not irradiated
(3), for 5 s with UV light 1 h before preparation of protein extracts. Expression levels of JNK and PAKs were determined by Western blotting
and shown not to vary between transfections. The data represent the results of three independent experiments, each performed in duplicate.
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PAK1s T405E or L98F also relieved Nck squelching, they
were no more e¡ective than wt PAK1. Under the conditions
in which PAK1 relieved Nck squelching of JNK activation,
PAK was also functionally linked to the EGF receptor by
Nck. Thus PAK cannot have alleviated Nck squelching by
sequestering Nck in an inactive state. Thus despite PAK1’s
inability to activate JNK, it still plays an integral role in the
JNK pathway, probably one that does not require catalytic
activity.
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tions of PAK1, PAK1 mutants T405E or L98F and Nck were
treated with UV, EGF or concurrently given both treatments 5 min
before preparation of extracts. PAK1 activity was measured using
MBP as substrate, see Section 2. B: Nck expression squelches the
rapid response of JNK to EGF and EGF plus UV but is counter-
acted by coexpression of xPAK1. Cells transfected with combina-
tions of xPAK1, xPAK1 mutants T405E, L98F and Nck were
treated with UV, EGF or both concurrently 5 min before prepara-
tion of extracts. JNK activities were normalized to those for the un-
stimulated cells. Expression levels of Nck are shown, but those of
JNK and PAKs were also determined by Western blotting and
shown to be equivalent in the di¡erent transfections. The data rep-
resent the results of three independent experiments, each performed
in duplicate.
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Fig. 3. PAK1 interacts with MLK2 and squelches super-activation
of JNK. A: Cells were transfected with combinations of MLK2 and
PAK1 or PAK mutants, Fig. 1A, and were treated with UV as in
Fig. 1. The data represent the mean of four independent experi-
ments, each performed in duplicate. B: Schematic representation of
MLK2 truncation mutants and their expression in whole embryo ex-
tracts. MLK2 proteins were visualized by immunoblotting via the
common N-terminal HA tag. C: Interaction of MLK2 with PAK1.
Whole embryo extracts expressing MLK2 truncation mutants (upper
panel) or in vitro translated mutants (lower panel) were incubated
with 1 Wg of immobilized full length PAK1 (GST-PAK1), the cata-
lytic domain of PAK1 (GST-CDPAK) or GST alone and bound
MLK2 was visualized either by immunoblotting using an anti-HA
antibody (upper panel) or phosphoimaging (lower panel).
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3.4. PAK1 interacts with MLK2 and regulates its ability to
activate JNK
Xenopus MLK2 was recently shown to be a true ortholog of
mammalian MLK2 and to function as a MAP3K for JNK,
[23]. Low-level over-expression of the Xenopus MLK2 did not
constitutively activate JNK, rather it enhanced the response of
JNK to stress signaling, thus simulating the probable in vivo
function of MLK in signal transduction. In contrast, previous
work had described the constitutive activation of JNK by
high-level over-expression of hMLK2 and hMLK3 [31^34].
However, such high-level over-expression probably led to
auto-activation of MLK via its homo-dimerization [35], po-
tentially explaining the apparent contradiction with our recent
data [23]. We also observed that during Xenopus development
PAK1 is often coexpressed with one or other member of the
MLK family, (S. Jean and N. Islam, unpublished data). We
therefore asked whether PAK1 might play a role in modulat-
ing MLK2 activation of JNK.
MLK2 and both wt and mutant PAK1s were cotransfected
into COS7 cells and the levels of JNK activation monitored
before and after UV treatment. Transfection of MLK2 en-
hanced UV activation of JNK by three-fold, Fig. 3A. How-
ever, all forms of PAK1 inhibited the MLK2 dependent acti-
vation of JNK and in several cases reduced it essentially to the
control levels, Fig. 3A. Wt PAK1 and the constitutively acti-
vated T405E and L98F were somewhat more e¡ective at in-
hibiting JNK activation than the dominant negative xPAK1-
T405A and -K281A, suggesting that in part this e¡ect re-
quired PAK1 catalytic activity or perhaps a speci¢c confor-
mation of the catalytic domain. We have also observed that
the K281A mutation signi¢cantly increases the a⁄nity of
xPAK1 for the GTP bound form of Cdc42, suggesting that
inhibition of JNK activation was not due to a squelching of
upstream GTPases (L. Poitras and N. Bisson, unpublished
data).
Whole protein extracts from Xenopus embryos expressing
MLK2 deletion mutants, Fig. 3C, were incubated with immo-
bilized GST-PAK1 and the retained proteins analyzed. As
shown in Fig. 3C, MLK2-Sph, -A£ and -Bam C-terminal
deletion mutants all bound speci¢cally to PAK1, while
MLK2-Eco, containing only the SH3 domain, did not detect-
ably bind. Thus, the interaction did not require the GBD or
leucine zipper (LZ)/basic domains of MLK2, nor was it medi-
ated by its SH3 domain. It did, however, require the MLK2
kinase domain. The PAK1 kinase domain alone was also able
to retain the MLK2 truncation mutant -SK, closely similar to
-A£, and the mutant -KZG lacking the N-terminal SH3 do-
main and all sequences downstream of the basic domain.
Thus, in large part the interaction between MLK2 and
PAK1 occurred between their kinase domains. Further experi-
ments con¢rmed that peptides containing the N-terminal SH-
3 binding sites of PAK1, see Fig. 1A, did not interact with the
SH3 domain of MLK2 (data not shown). MLK2-Sph and
-A£, which both contained a complete kinase domain and
LZ, bound somewhat better to PAK1 than did MLK2-Bam,
which lacked the LZ motif, Fig. 3C. This suggested that di-
merization of xMLK2 might play a role in the interaction
between these kinases, possibly by permitting a cooperative
interaction of the PAK1 kinase domain with the kinase do-
mains of an MLK2 dimer. Thus PAK1 and MLK2 interact
both physically and functionally.
4. Discussion
We have shown that while Xenopus PAK1 is unable to
function as a MAP4K to activate JNK in COS7 cells, it none-
theless is a component of the JNK signaling cascade. Our
evidence is two-fold. Firstly, squelching of the immediate
phase of JNK activation by the adapter Nck is alleviated by
PAK1 expression. Secondly, PAK1 interacts with the MAP3K
MLK2 and suppresses its capacity to activate JNK.
Over-expression of the SH3^SH2 adapter Nck was shown
to suppress JNK activation. Similarly, Nck over-expression
has been shown to e¡ectively act as a dominant negative mu-
tation in other systems [28,29]. This is probably due to non-
stochiometric expression of Nck relative to the other compo-
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nents of a signal transduction pathway, e.g. see Fig. 4B, and
as such closely resembles ‘squelching’, an e¡ect in which an
excess of a transcriptional activator represses gene transcrip-
tion by titrating essential coactivators [30]. Strikingly, when
PAK1 was coexpressed with Nck it relieved squelching of
JNK activation. This was not simply due to a sequestration
of Nck into an inactive complex, since at the same time acti-
vation of PAK1 by EGF was completely dependent on Nck,
though, it could equally be explained by PAK1 being able to
displace a factor essential for JNK activation from Nck.
MLK2, [23] mediates a super-activation of JNK in response
to UV stress. But in contrast to its palliative e¡ects on Nck
squelching, PAK1 squelched MLK2 super-activation of JNK.
The e¡ect was in greater part independent of PAK1 kinase
activity, though activated forms of PAK1 suppressed the ef-
fects of MLK2 somewhat better than did inactivated forms.
MLK2 and PAK1 were also shown to interact via their kinase
domains, suggesting that PAK1 squelching of JNK super-ac-
tivation was due to direct interaction with MLK2, e.g. see Fig.
4C. More distantly related members of the Ste20 kinase family
such as the GCK subfamily kinase HPK1 also bind MLKs
[36,37], though in these cases the interactions do not involve
the kinase domains. Thus, the ability to bind MLKs may be a
more general property of Ste20 family kinases.
Our data are consistent with a novel non-catalytic function
for PAK1 as a sca¡olding element in a signal transduction
network linking tyrosine kinase receptors to the MLK-JNK
cascade, Fig. 4A. In this network, activated receptors could
recruit the JNK cascade to the plasma membrane via PAK1
and MLK2. This recruitment would allow the activation of
MLK2 by the intervention of the membrane tethered small
GTPase Rac or GCK subfamily kinases such as HPK1. In
this model, PAK1 would function predominantly as a scaf-
folding protein. Indeed, the PAKs have been shown to display
kinase independent e¡ects [38]. Further, the schematic model
in Fig. 4 resembles the bifurcated dorsal closure pathway in
Drosophila [39]. This pathway, which leads to activation of
DMLK (Slipper) and hence DJNK, passes via parallel
DRac/DPAK and GCK kinase (misshapen, MSN) dependent
branches [40].
Since their discovery, the PAKs have provided a potential
but elusive link between the Rho GTPases Rac and Cdc42
and the JNK cascade. However, it is becoming more and
more clear that the major phosphorylation substrates of the
PAKs do not lie within these cascades [41]. Further, while the
PAKs can be activated by Rac and Cdc42, they have also
been found to suppress the Rac/Cdc42 dependent activation
of JNK [18,19]. This is clearly inconsistent with a role for
PAK1 as a MAP4K. Despite this, a range of studies have in
fact implicated the PAKs in the modulation of JNK or p38
activation [16^18]. Our data suggest that at least in part these
studies, in all of which PAKs have been over-expressed, may
be the result of squelching events such as those we describe
here.
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